NewsBenzingaCVRx abaisse ses prévisions de ventes pour l’exercice 2026 de 58,000 M$-60,000 M$ à 56,000 M$-57,000 M$ contre 58,950 M$ estimés CVRx abaisse ses prévisions de ventes pour l’exercice 2026 de 58,000 M$-60,000 M$ à 56,000 M$-57,000 M$ contre 58,950 M$ estimés Benzinga 2026.11.05 21:17 (GMT+0) Open on Benzinga Other news JP Morgan Maintains Overweight on Ashland, Raises Price Target to $82 JP Morgan Maintains Neutral on ArcBest, Raises Price Target to $164 JP Morgan Maintains Overweight on Dave, Lowers Price Target to $435 Chip Stocks Just Had Their Worst Day Since 2020: 28 of 30 Biggest Names Are in a Bear Market $1000 Invested In Novartis 5 Years Ago Would Be Worth This Much Today JP Morgan Maintains Underweight on Avis Budget Gr, Lowers Price Target to $85
